Chronic News and Research

RSS

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.

13 Jan 2011

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.

13 Jan 2011

Scientists quantify amount of energy lost during sleep deprivation

American scientists have quantified for the first time ever the amount of energy lost during a night of sleep deprivation according to new research published in The Journal of Physiology.

13 Jan 2011

GSK, ChemoCentryx initiate '786 Phase III clinical trial for Crohn's disease

GlaxoSmithKline and ChemoCentryx, announced today that the first patient with Crohn's disease has initiated treatment in the initial pivotal induction study comparing Traficet-EN, now designated GSK1605786 ('786), to placebo.

12 Jan 2011

NSAIDs raise risk of heart disease: Study

A new study published online in the British Medical Journal explores the relative safety of non-steroidal anti-inflammatory medications (NSAIDs), commonly used to treat joint and muscle aches and pain and concludes that NSAIDs significantly increase the risk of cardiovascular events in patients who take them regularly.

12 Jan 2011

Endosense initiates enrollment in TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

Endosense, a medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias, has announced first patient enrollment in the TOCCASTAR (TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation) clinical study at Na Homolce Hospital, Prague, Czech Republic, by study investigator Petr Neuzil, M.D.

12 Jan 2011

UnitedHealthcare selects Millennium as participating provider of pain management services

Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, announced it will provide pain management and therapeutic drug monitoring services to physicians participating in UnitedHealthcare's national care provider network.

12 Jan 2011

Lightning Process training course tops in survey by ME/ CFS

A revolutionary self training course has emerged top in a survey conducted by the Sussex and Kent ME/ CFS Society.

12 Jan 2011

U.N. has 'largely' met its goals in Haiti since the quake, official says

The U.N. has mostly achieved its short-term goals since a major earthquake struck Haiti on January 12, 2010, Nigel Fisher, the U.N. humanitarian coordinator for Haiti, said during a video teleconference on Monday, Deutsche Presse-Agentur/M&C reports.

12 Jan 2011

Physicians who completed internal medicine training lack primary care knowledge: Study

Doctors who have completed training in internal medicine are in general poorly prepared for jobs as primary care physicians, most notably lacking the knowledge to best care for patients with chronic conditions such as diabetes, hypertension and high cholesterol, new Johns Hopkins research suggests.

12 Jan 2011

Lancet series examines health challenges in India

"Indians are growing richer, but they are also adopting unhealthy lifestyles that could take years off their lives and threaten economic growth," according to an article published in Lancet Tuesday, Agence France-Presse reports (1/11). The article is one of seven published in the Lancet as part of a series that also includes a set of commentary pieces on health issues facing the country (1/11).

12 Jan 2011

UH, Case Western University commence clinical trial for bipolar disorder

The Mood Disorders Program at Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, along with the Bipolar Trials Network, is launching Bipolar CHOICE.

12 Jan 2011

Aid workers should pay extra attention to girls during food insecurity, say researchers

In situations of chronic food shortage, parents are inclined to give boys a preferential treatment. Anyway, the health of their daughters suffers more from food insecurity. This is shown by research fromp the Institute of Tropical Medicine in Ethiopia, appearing in the journal Pediatrics.

12 Jan 2011

GE and KeyHIE expand Pennsylvania's health information exchange

GE Healthcare and Keystone Health Information Exchange, which serves central and northeast Pennsylvania communities, have announced they are expanding the region's health information exchange to augment its chronic disease management capabilities and broaden its reach to many more healthcare providers.

12 Jan 2011

IOF welcomes EU Council Conclusions on chronic diseases, urges action in member states

According to the World Health Organization, chronic diseases are by far the leading cause of mortality in the world, representing 60% of all deaths worldwide and imposing an enormous burden on patients, their families and on society as a whole.

12 Jan 2011

Herpes zoster vaccine reduces risk of developing shingles by 55%

Receiving the herpes zoster vaccine was associated with a 55 percent reduced risk of developing shingles, according to a Kaiser Permanente study of 300,000 people that appears in the current issue of the Journal of the American Medical Association.

12 Jan 2011

Avinger raises $25 million for catheter development and commercialization

Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating peripheral artery disease (PAD), recently completed a $25 million Series B round of funding from a syndicate of highly successful entrepreneurs and executives.

12 Jan 2011

Emerging Healthcare enters option agreement with OceanBASIS

Emerging Healthcare Solutions, Inc. announced today that it has entered into an option agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.

12 Jan 2011

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

Boehringer Ingelheim and Eli Lilly and Company today announced a global agreement to jointly develop and commercialize a portfolio of diabetes compounds currently in mid- and late-stage development.

12 Jan 2011

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Merck today announced that the New Drug Application (NDA) for the Company's investigational extended-release formulation of JANUMET for type 2 diabetes has been accepted for standard review by the U.S. Food and Drug Administration (FDA). The Company is also moving forward as planned with regulatory filings in countries outside the United States.

12 Jan 2011

Chronic News and Research

FibroGen initiates FG-3019 open-label phase 2 study in idiopathic pulmonary fibrosis

Pfizer initiates rolling submission of crizotinib NDA for ALK-positive advanced NSCLC

Scientists quantify amount of energy lost during sleep deprivation

GSK, ChemoCentryx initiate '786 Phase III clinical trial for Crohn's disease

NSAIDs raise risk of heart disease: Study

Endosense initiates enrollment in TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation

UnitedHealthcare selects Millennium as participating provider of pain management services

Lightning Process training course tops in survey by ME/ CFS

U.N. has 'largely' met its goals in Haiti since the quake, official says

Physicians who completed internal medicine training lack primary care knowledge: Study

Lancet series examines health challenges in India

UH, Case Western University commence clinical trial for bipolar disorder

Aid workers should pay extra attention to girls during food insecurity, say researchers

GE and KeyHIE expand Pennsylvania's health information exchange

IOF welcomes EU Council Conclusions on chronic diseases, urges action in member states

Herpes zoster vaccine reduces risk of developing shingles by 55%

Avinger raises $25 million for catheter development and commercialization

Emerging Healthcare enters option agreement with OceanBASIS

Eli Lilly, Boehringer Ingelheim enter global agreement to develop and commercialize diabetes compounds

FDA accepts Merck's JANUMET extended-release formulation NDA for type 2 diabetes

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News